Drdgold (DRD) Shares Outstanding (Weighted Average) (2017 - 2025)

Drdgold has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $339.3 million for Q2 2025.

• Shares Outstanding (Weighted Average) for Q2 2025 came in at $339.3 million, up 631.13% year-over-year; the trailing twelve-month figure through Jun 2025 was $339.3 million (up 631.13% YoY), and the FY2025 annual result was $339.3 million, up 631.13% from the prior year.
• Shares Outstanding (Weighted Average) came in at $339.3 million for Q2 2025 at Drdgold, up from $46.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $435.5 million in Q2 2021 to a low of $46.4 million in Q2 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $339.3 million (2025), against an average of $310.4 million.
• Across the five-year window, Shares Outstanding (Weighted Average) sank 86.05% in 2024 and jumped 631.13% in 2025, its largest moves.
• Drdgold's Shares Outstanding (Weighted Average) stood at $435.5 million in 2021, then retreated by 8.52% to $398.3 million in 2022, then retreated by 16.49% to $332.7 million in 2023, then sank by 86.05% to $46.4 million in 2024, then surged by 631.13% to $339.3 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $339.3 million (Q2 2025), $46.4 million (Q2 2024), and $332.7 million (Q2 2023), per Business Quant data.